| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Trisalus Life Sciences, Inc.'s insiders have reduced their positions by a net 937 shares worth roughly $4K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.64M | $5.71M | - | |
| Dir | 1.32M | $4.60M | - | |
| CEO | 1.07M | $3.74M | - | |
| Dir | 542.8K | $1.89M | - | |
| CFO | 261.1K | $908.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Mats Wahlstrom61 | Director, 10% Owner | Buy | 5,000 | $4.55 | $22,750.00 | +46.6% | +26.3% | +11.9% | |
| Nov 21, 2024 | Mats Wahlstrom61 | Director, 10% Owner | Buy | 10,727 | $4.39 | $47,056.68 | New | +29.1% | +14.4% | |
| Oct 5, 2024 | Bryan F. Cox57 | Chief Scientific & Manufact. | Sell | 314 | $4.44 | $1,394.16 | -0.4% | +10.3% | +1.8% | |
| Sep 13, 2024 | Mary T Szela52 | CEO and President | Buy | 14,815 | $5.09 | $75,358.85 | +4.0% | -12.2% | -2.0% | |
| Sep 10, 2024 | Mary T Szela52 | CEO and President | Buy | 5,000 | $4.97 | $24,850.00 | +1.4% | -16.2% | -5.2% | |
| Aug 28, 2024 | George Kelly Martin | - | Sell | 9 | $5.50 | $49.50 | - | -13.4% | +2.4% |